Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why MannKind Stock Soared 19% Higher on Tuesday


Commercial-stage biotech MannKind (NASDAQ: MNKD) was a top choice of investors on the second day of the trading week. Tuesday saw MannKind's share price leap by almost 19%, making it stand out on a day when the S 500 index slumped by 0.4%. 

The reason for the stock's jump wasn't hard to tease out.

MannKind, which concentrates on developing treatments for endocrine and lung disorders, published its second quarter results that day.

Continue reading


Source Fool.com

MannKind Corp. Stock

€3.31
-0.570%
The price for the MannKind Corp. stock decreased slightly today. Compared to yesterday there is a change of -€0.019 (-0.570%).
With 27 Buy predictions and not a single Sell prediction MannKind Corp. is an absolute favorite of our community.
With a target price of 7 € there is potential for a 111.8% increase which would mean more than doubling the current price of 3.31 € for MannKind Corp..
Like: 0
Share

Comments